Rare diseases
Investigational molecules
Locations
Study of PF-07275315 versus placebo for efficacy and safety in adults with moderate-to-severe chronic obstructive pulmonary disease (COPD)
GermanyPhase 3 Randomized, Double‑Blind, Placebo‑Controlled Study of ALKS 2680 for Excessive Daytime Sleepiness in Adults with Narcolepsy Type 2
GermanyPhase 3 Randomized Study of ALKS 2680 for Excessive Daytime Sleepiness in Adults with Narcolepsy Type 1
GermanyEvaluation of Anifrolumab Subcutaneous Treatment in Immunosuppressant‑Naïve and Biologic‑Naïve Patients with Systemic Lupus Erythematosus
GermanyEfficacy and safety of indacaterol acetate (combined with glycopyrronium bromide and mometasone furoate) versus salmeterol/fluticasone in adolescents with asthma
GermanyLong-term Safety and Efficacy of Remibrutinib in Adults with Moderate to Severe Hidradenitis Suppurativa
GermanyBI 764198 in Adults and Adolescents with Proteinuric Kidney Diseases
GermanyOrelabrutinib in Patients with Primary Progressive Multiple Sclerosis
GermanyZenagamtide Compared with Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes
GermanyLong-Term Safety and Efficacy of Zasocitinib in Adults with Active Psoriatic Arthritis
GermanyComparison of Obicetrapib and Bempedoic Acid in Patients with Dyslipidemia at High to Very High Cardiovascular Risk
GermanyLong-Term Safety and Efficacy of Lebrikizumab in Children and Adolescents With Moderate-to-Severe Atopic Dermatitis
GermanyTell us about your condition – we search every trial in Europe and connect you with the right site.
